-
Another New Blood Thinner FDA Approved : Xarelto (Rivaroxaban)
Today the FDA approved Xarelto (Rivaroxaban) for irregular heart beat (= atrial fibrillation = a. fib). The approved dose is 20 mg once daily. The link to the FDA press release is here. The Xarelto prescribing information can be found here. Xarelto for Blood Clots in the Veins (DVT and PE)
-
Rivaroxaban (Xarelto): FDA Advisory Board Recommends Against Approval for Atrial Fibrillation
Surprise to many people today: An FDA staff report released today (Sept 6th, 2011) states that FDA reviewers recommend against the approval of rivaroxaban (Xarelto) for the atrial fibrillation indication. A detailed discussion with reasons for the recommendation can be found here. The main reason: It has not been shown that rivaroxaban is as effective as…
A Clearinghouse for Information about Blood Clots (DVT/)PE) and Clotting Disorders (thrombophilia) provided as a public service by the University of North Carolina Blood Research Center
Clot Connect 